🇨🇦 Canada Country × Condition
alzheimer disease Clinical Trials in Canada
Active clinical trials for alzheimer disease with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇨🇦 Canada
Active Trials in Canada (4)
NCT05509387
Recruiting
Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease
Enrollment
42 pts
Country
🇨🇦 Canada
Baycrest
View Trial → NCT07221344 Phase 1, Phase 2
Recruiting
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
Enrollment
112 pts
Country
🇨🇦 Canada
Arrowhead Pharmaceuticals
View Trial → NCT06732128
Recruiting
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
Enrollment
50 pts
Country
🇨🇦 Canada
Centre for Addiction and Mental Hea...
View Trial → NCT06947941 Phase 3
Recruiting
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Enrollment
325 pts
Country
🇨🇦 Canada
Bristol-Myers Squibb
View Trial → Frequently Asked Questions
How many alzheimer disease clinical trials are active in Canada?
There are currently 4 active clinical trials for alzheimer disease with sites in Canada, of which 4 are actively recruiting patients.
How can I join a alzheimer disease clinical trial in Canada?
To join a alzheimer disease clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are alzheimer disease trials in Canada?
Active alzheimer disease trials in Canada span Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology